An experimental drug might help slow early Alzheimer’s disease in a markedly different way than today’s treatments — by ...

But a new study has found the same protein does something researchers did not expect; helping healthy brains build memories ...

The FDA approved a new starting dosage regimen for the subcutaneous formulation of lecanemab (Leqembi Iqlik) to treat adults ...

Last month, I watched in dismay as Director Jay Bhattacharya stood before 1,000 Alzheimer’s disease and dementia advocates ...

What is sound therapy? Researchers are working to crack the link between audiovisual stimulation and Alzheimer's.

"We are taking a really different approach to Alzheimer's. We've determined how neural activity that is essential for memory fails." ...

New clinical and real-world data support a subcutaneous treatment pathway from initiation through maintenance treatment, ...

Stay informed with the latest news and expert insights on Alzheimer’s disease here. In our efforts to keep our brains healthy, how do we know what is working? Helen Thomson explores a new generation o ...

Many Alzheimer's medications slow the disease, but this non-drug treatment helped patients improve.

Whether it's building separate bike lanes, improving public transportation, or increasing density in downtown areas, we have ...

Blood test results help primary care physicians diagnose Alzheimer’s disease with near-specialist accuracy while influencing ...

Biogen and Ionis said Tuesday their tau-targeting Alzheimer's treatment slowed cognitive decline by 26% over the course of 18 months.